Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (651-660 of 679) with videos related to

Pageof 68
Sort By:
Journal of Psychiatric Research|March 28, 2025
Prediction of postoperative delirium by blood metabolome analysisNaohiro Arai, Yuki Sugiura, Shinichiro Nakajima, et al.
Molecular Psychiatry|December 16, 2024
Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depressionYuzuki Ishikawa, Naoya Oishi, Yusuke Kyuragi, et al.
Journal of Geriatric Psychiatry and Neurology|August 4, 2023
Late-Life High Blood Pressure and Enlarged Perivascular Spaces in the Putaminal Regions of Community-Dwelling Japanese Older PersonsAyumi Tachibana, Jun-Ichi Iga, Yasuko Tatewaki, et al.
Molecular Psychiatry|September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studiesTomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Brain : a Journal of Neurology|September 11, 2019
PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injuryKeisuke Takahata, Yasuyuki Kimura, Naruhiko Sahara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2026
Florzolotau (18F) retention is linked to neuropsychological performance in tauopathyAtsushi Shimizu, Yu Iwabuchi, Shogyoku Bun, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Alzheimer'S Research & Therapy|June 7, 2025
Plasma biomarkers for early detection of alzheimer's disease: a cross-sectional study in a Japanese cohortMasahito Kubota, Shogyoku Bun, Keisuke Takahata, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Brain Communications|October 11, 2021
Evaluation of [<sup>18</sup>F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathiesToshiki Tezuka, Keisuke Takahata, Morinobu Seki, et al.
Pageof 68

Showing results (651-660 of 679) with videos related to

Sort By:
Pageof 68
Journal of Psychiatric Research|March 28, 2025
Prediction of postoperative delirium by blood metabolome analysisNaohiro Arai, Yuki Sugiura, Shinichiro Nakajima, et al.
Molecular Psychiatry|December 16, 2024
Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depressionYuzuki Ishikawa, Naoya Oishi, Yusuke Kyuragi, et al.
Journal of Geriatric Psychiatry and Neurology|August 4, 2023
Late-Life High Blood Pressure and Enlarged Perivascular Spaces in the Putaminal Regions of Community-Dwelling Japanese Older PersonsAyumi Tachibana, Jun-Ichi Iga, Yasuko Tatewaki, et al.
Molecular Psychiatry|September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studiesTomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Brain : a Journal of Neurology|September 11, 2019
PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injuryKeisuke Takahata, Yasuyuki Kimura, Naruhiko Sahara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2026
Florzolotau (18F) retention is linked to neuropsychological performance in tauopathyAtsushi Shimizu, Yu Iwabuchi, Shogyoku Bun, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Alzheimer'S Research & Therapy|June 7, 2025
Plasma biomarkers for early detection of alzheimer's disease: a cross-sectional study in a Japanese cohortMasahito Kubota, Shogyoku Bun, Keisuke Takahata, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Brain Communications|October 11, 2021
Evaluation of [<sup>18</sup>F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathiesToshiki Tezuka, Keisuke Takahata, Morinobu Seki, et al.
Pageof 68